Loading…

Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis

Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular biochemistry 1998-10, Vol.187 (1-2), p.211
Main Authors: Yamada, Hisashi, Horiguchi-yamada, Junko, Nagai, Makoto, Takahara, Shinobu, Sekikawa, Tetsuaki, Kawano, Takeshi, Itoh, Kiyoshi, Fukumi, Sachiko, Iwase, Satsuki
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1-2
container_start_page 211
container_title Molecular and cellular biochemistry
container_volume 187
creator Yamada, Hisashi
Horiguchi-yamada, Junko
Nagai, Makoto
Takahara, Shinobu
Sekikawa, Tetsuaki
Kawano, Takeshi
Itoh, Kiyoshi
Fukumi, Sachiko
Iwase, Satsuki
description Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]
doi_str_mv 10.1023/A:1006874931249
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_756250442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2153448891</sourcerecordid><originalsourceid>FETCH-proquest_journals_7562504423</originalsourceid><addsrcrecordid>eNqNjs1OwzAQhC0EEqFw5rriXFM7P03TW6EgJK7cK9fZUFeWN9gOKA_FO-IGHoDTSDPfzixjt1LcS5EXi81aCrFc1WVTyLxszlgmq7rgZSObc5aJQgi-knV9ya5COAqRYCkz9v1gyNK70coCdh3qGIA6UODRqmg-0Y5g6Qs0OY0u-uSROxGS7_mWK6_2xlE3eOUojFaPkYJxCMbBa7XMQaO1YQ0bG_H3dqqPB5wS0KO2OAf0Yzx4Mi1vTXrCpyUz0XNQrgXVU3_qDdfsolM24M2fztjd89Pb4wvvPX0MGOLuSIN3KdrVab0SZZkX_4J-AGYJZuI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756250442</pqid></control><display><type>article</type><title>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</title><source>Springer Nature</source><creator>Yamada, Hisashi ; Horiguchi-yamada, Junko ; Nagai, Makoto ; Takahara, Shinobu ; Sekikawa, Tetsuaki ; Kawano, Takeshi ; Itoh, Kiyoshi ; Fukumi, Sachiko ; Iwase, Satsuki</creator><creatorcontrib>Yamada, Hisashi ; Horiguchi-yamada, Junko ; Nagai, Makoto ; Takahara, Shinobu ; Sekikawa, Tetsuaki ; Kawano, Takeshi ; Itoh, Kiyoshi ; Fukumi, Sachiko ; Iwase, Satsuki</creatorcontrib><description>Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1023/A:1006874931249</identifier><language>eng</language><publisher>New York: Springer Nature B.V</publisher><subject>Apoptosis ; Biological effects ; Cell cycle ; Deoxyribonucleic acid ; DNA ; Leukemia ; Proteins</subject><ispartof>Molecular and cellular biochemistry, 1998-10, Vol.187 (1-2), p.211</ispartof><rights>Kluwer Academic Publishers 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Horiguchi-yamada, Junko</creatorcontrib><creatorcontrib>Nagai, Makoto</creatorcontrib><creatorcontrib>Takahara, Shinobu</creatorcontrib><creatorcontrib>Sekikawa, Tetsuaki</creatorcontrib><creatorcontrib>Kawano, Takeshi</creatorcontrib><creatorcontrib>Itoh, Kiyoshi</creatorcontrib><creatorcontrib>Fukumi, Sachiko</creatorcontrib><creatorcontrib>Iwase, Satsuki</creatorcontrib><title>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</title><title>Molecular and cellular biochemistry</title><description>Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]</description><subject>Apoptosis</subject><subject>Biological effects</subject><subject>Cell cycle</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Leukemia</subject><subject>Proteins</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNjs1OwzAQhC0EEqFw5rriXFM7P03TW6EgJK7cK9fZUFeWN9gOKA_FO-IGHoDTSDPfzixjt1LcS5EXi81aCrFc1WVTyLxszlgmq7rgZSObc5aJQgi-knV9ya5COAqRYCkz9v1gyNK70coCdh3qGIA6UODRqmg-0Y5g6Qs0OY0u-uSROxGS7_mWK6_2xlE3eOUojFaPkYJxCMbBa7XMQaO1YQ0bG_H3dqqPB5wS0KO2OAf0Yzx4Mi1vTXrCpyUz0XNQrgXVU3_qDdfsolM24M2fztjd89Pb4wvvPX0MGOLuSIN3KdrVab0SZZkX_4J-AGYJZuI</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Yamada, Hisashi</creator><creator>Horiguchi-yamada, Junko</creator><creator>Nagai, Makoto</creator><creator>Takahara, Shinobu</creator><creator>Sekikawa, Tetsuaki</creator><creator>Kawano, Takeshi</creator><creator>Itoh, Kiyoshi</creator><creator>Fukumi, Sachiko</creator><creator>Iwase, Satsuki</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>19981001</creationdate><title>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</title><author>Yamada, Hisashi ; Horiguchi-yamada, Junko ; Nagai, Makoto ; Takahara, Shinobu ; Sekikawa, Tetsuaki ; Kawano, Takeshi ; Itoh, Kiyoshi ; Fukumi, Sachiko ; Iwase, Satsuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_7562504423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Apoptosis</topic><topic>Biological effects</topic><topic>Cell cycle</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Leukemia</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Horiguchi-yamada, Junko</creatorcontrib><creatorcontrib>Nagai, Makoto</creatorcontrib><creatorcontrib>Takahara, Shinobu</creatorcontrib><creatorcontrib>Sekikawa, Tetsuaki</creatorcontrib><creatorcontrib>Kawano, Takeshi</creatorcontrib><creatorcontrib>Itoh, Kiyoshi</creatorcontrib><creatorcontrib>Fukumi, Sachiko</creatorcontrib><creatorcontrib>Iwase, Satsuki</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Hisashi</au><au>Horiguchi-yamada, Junko</au><au>Nagai, Makoto</au><au>Takahara, Shinobu</au><au>Sekikawa, Tetsuaki</au><au>Kawano, Takeshi</au><au>Itoh, Kiyoshi</au><au>Fukumi, Sachiko</au><au>Iwase, Satsuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis</atitle><jtitle>Molecular and cellular biochemistry</jtitle><date>1998-10-01</date><risdate>1998</risdate><volume>187</volume><issue>1-2</issue><spage>211</spage><pages>211-</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>Therapeutic strategies for leukemia are directed to induction of differentiation and apoptosis as well as growth inhibition. One of the key antileukemic agents, 1-β-D-arabinofuranosylcytosine (ara C), is clinically applied according to these therapeutic aims. However, the molecular effects of 0.1 μg/ml of ara C, a concentration that corresponds to the serum level in leukemic patients on a conventional dose of ara C, have not been well disclosed. Here, we addressed these issues using K562 cells which derived from a blastic crisis of chronic myeloid leukemia. DNA synthesis of treated cells was suppressed from 1-6 h. But, it recovered at 12 h and no further inhibition was observed. The number of cells was not decreased but DNA fragmentation was observed at 72 h. The number of erythroid-differentiated cells also increased to 30% at 72 h. Along with treatment, no marked alteration of mRNAs for cell cycle-regulating genes was found and the retinoblastoma gene product remained hyperphosphorylated throughout treatment. The expression of mRNAs for apoptosis-regulating genes also remained unchanged, except for slight down-regulation of Bax. c-myc protein was not found later than 48 h, and Max mRNA was downregulated. c-jun was immediately induced, followed by the fluctuated expression level along with treatment. These findings suggest that the 0.1 μg/ml ara C changed the proliferation, differentiation and death of K562 cells in a biphasic manner. In the early phase, DNA synthesis was inhibited without altering the expression of cell cycle regulating-genes. In the latter phase, cell death and erythroid- differentiation occurred in accordance with the down-regulation of c-myc.[PUBLICATION ABSTRACT]</abstract><cop>New York</cop><pub>Springer Nature B.V</pub><doi>10.1023/A:1006874931249</doi></addata></record>
fulltext fulltext
identifier ISSN: 0300-8177
ispartof Molecular and cellular biochemistry, 1998-10, Vol.187 (1-2), p.211
issn 0300-8177
1573-4919
language eng
recordid cdi_proquest_journals_756250442
source Springer Nature
subjects Apoptosis
Biological effects
Cell cycle
Deoxyribonucleic acid
DNA
Leukemia
Proteins
title Biological effects of a relatively low concentration of 1-b-D-arabinofuranosylcytosine in K562 cells: Alterations of the cell cycle, erythroid-differentiation, and apoptosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A01%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biological%20effects%20of%20a%20relatively%20low%20concentration%20of%201-b-D-arabinofuranosylcytosine%20in%20K562%20cells:%20Alterations%20of%20the%20cell%20cycle,%20erythroid-differentiation,%20and%20apoptosis&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Yamada,%20Hisashi&rft.date=1998-10-01&rft.volume=187&rft.issue=1-2&rft.spage=211&rft.pages=211-&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1023/A:1006874931249&rft_dat=%3Cproquest%3E2153448891%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_7562504423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=756250442&rft_id=info:pmid/&rfr_iscdi=true